Proaño LNE, Arévalo OIM

Language: Spanish
References: 16
Page: 150-154
PDF size: 283.70 Kb.

ABSTRACT

Systemic lupus erythematosus is an autoimmune rheumatic disease complex multisystem with significant potential for morbidity and mortality. It has a worldwide distribution that affects all races.
Objective: To review the main manifestations of systemic lupus erythematosus that may be of interest to the binomial rheumatologist-dermatologist in the diagnosis and monitoring of this autoimmune rheumatic disease.
Development: among the publications within the period 2010-2015, a systematic search was conducted for scientific information available related to the subject, in LILACS, PubMed, Altavista and Google Scholar, using the terms "systemic lupus erythematosus", "injury and dermatologic manifestations ". The search strategy was modified by adding the words "clinical practice guidelines". The search was limited to articles written in Spanish and English. As exclusion criteria, clinical trials and case reports were not selected.
Conclusions: early diagnosis and treatment are vital to achieve control of the disease and prevent its progress towards functional disability and reduced quality of patients’ lives. Therefore, updating the knowledge of the binomial-dermatologist rheumatologist enables empowerment oriented towards a comprehensive therapeutic approach, eradicating or at least mitigating the difficulties doctors face at the time of diagnosis and monitoring of these patients.

REFERENCES

1. Cassidy JT, Petty RE. Systemic connective tissue diseases. En: Textbook of Pediatric Rheumatology, 6th ed. Philadelphia: Elsevier Saunders; 2011. p. 315-478.

2. Alonso MD, Llorca J, Martínez Vázquez F, et al. Systemic lupus erythematosus in northwestern Spain: a 20-year epidemiologic study. Medicine 2011; 90:350-358.

3. Tsokos GC. Systemic lupus erythematosus. N Engl J Med 2011;365:2110-2121.

4. Tan TC, Fang H, Magder LS, Petri MA. Differences between Male and Female Systemic Lupus Erythematosus in a Multiethnic Population. J Rheumatol 2012;1.

5. Pedraz Penalva T, Bernabeu Gonzálvez P, Vela Casasempere P. Enfermedades reumáticas: Actualización SVR. Lupus Eritematoso Sistémico [Internet]. 2008[citado 2 julio 2016]. Disponible en: http://www.svreumatologia.com/wp-content/uploads/2008/04/Cap-6-Lupus-eritematoso-sistemico.pdf

6. Graziola Trujillo-Martín MM, Rúa-Figueroa Fernández de Larrinoa I, Ruíz-Irastorza G3, Pego-Reigosa JM, Sabio Sánchez JM5, Serrano-Aguilar P.Clinical practice guidelines for systemic lupus erythematosus: Recommendations for general clinical management].Med Clin (Barc). [Internet]. 2016 [citado 2 julio 2016];146(9):413-414. Disponible en: doi: 10.1016/j.medcli.2016.01.013.

7. Conti F1, Ceccarelli F2, Perricone C2, Leccese I2, Massaro L2, Pacucci VA2, Truglia S2, Miranda F2, Spinelli FR2, Alessandri C2, Valesini G2.Lupus. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort. [Internet]. 2016 [citado 2 julio 2016]; [Epub ahead of print]Disponible en: DOI: 10.1177/0961203315627199

8. Guibert Toledano ZM. Actividad lúpica y daño acumulado en una cohorte de pacientes cubanos con lupus eritematoso sistémico (LES). Servicio Nacional de Reumatología[Tesis doctoral].2010. Disponible en: http://tesis.repo.sld.cu/126/1/Zoila_Marlene_Guibertoledano.pdf

9. Jiménez S, Cervera R, Font J, Ingelmo M. The epidemiology of Systemic Lupus Erythematosus. Clin Rev Allergy Immunol. 2003;25 (1):3-12.

10. Guibert Toledano ZM, Reyes Llerena GA, Rigñack Ramírez L, Cruz García Y, Acosta Lapera D, Salgado Galloso SB. Embarazo y puerperio en el lupus eritematoso sistémico. Actualización. Revista Cubana de Reumatología [Internet]. 2013 [citado 2016 Jul 4];15(2). Disponible en: http://www.revreumatologia.sld.cu/index.php/reumatologia/article/view/216

11. Vidal L, Aguilar J, Piscoya J. Bases y principios en reumatología. Manifestaciones cutáneas de las enfermedades reumáticas. 2º ed. Lima: Boehringer Ingelheim Editores; 1997. p.531-6.

12. Salomón M, Samalvides F, Gordillo J, Gutierrez C.Manifestaciones histopatológicas del lupus eritematoso cutáneo en pacientes del Servicio de Dermatología del Hospital Nacional Cayetano Heredia, 2003-2008. Folia dermatol. Peru [Internet]. 2009 [citado 2 julio 2016]; 20 (2): 64-70. Disponible en: http://sisbib.unmsm.edu.pe/bvrevistas/folia/vol20_n2/pdf/a02v20n2.pdf

13. Grupo de Estudio de Enfermedades Autoinmunes Sistémicas (GEAS) Sociedad Española de Medicina Interna (SEMI) .Guías clínicas de enfermedades AUTOINMUNES SISTÉMICAS. Lupus Eritematoso Sistémico. 2011 Disponible en: http://www.chospab.es/biblioteca/libros/GUIA_LUPUS_ERITOMASO.pdf

14. American College of Rheumatology Ad Hoc Committee on Systemic Lupus. Erythematosus Response Criteria. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity. Arthritis Rheum. 2004; 50:3418-26.

15. Mok CC, Lee KW, Ho CT et al. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology (Oxford)2000;39(4):399-406.

16. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10 -year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003;82(5):299-308.